Beta-Synuclein in CSF as Early Diagnostic Marker of Alzheimer Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Beta-Synuclein in Cerebrospinal Fluid as an Early Diagnostic Marker of Alzheimer's Disease
J. Neurol. Neurosurg. Psychiatr. 2020 Dec 30;[EPub Ahead of Print], S Halbgebauer, P Oeckl, P Steinacker, D Yilmazer-Hanke, S Anderl-Straub, C von Arnim, L Froelich, LA Gomes, L Hausner, A Huss, H Jahn, J Weishaupt, AC Ludolph, DR Thal, M OttoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.